We determined the presence of the mutant TERT promoter in urinary DNA derived from BC and RPC patients (collected prior to surgical treatment) using Sanger Sequencing, and 96% specificity with 60% sensitivity was achieved [80,122,136]. This evidence concerns the gene TERT and familial reactive perforating collagenosis.